Use of Remote Patient Monitoring (RPM) Platform for COVID-19 Patient
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- COVID
- Sponsor
- Montefiore Medical Center
- Enrollment
- 300
- Locations
- 1
- Primary Endpoint
- Number of Monitored Versus Non-Monitored In-patient Admission
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The central hypothesis motivating this study is that remote patient monitoring (RPM) of infectious disease patients can efficiently facilitate self-isolation. Additionally, RPM can assist in more rapid identification of patients at risk, facilitate detection of patient deterioration, and enable early interventions, all of which play a vital role in resource utilization and outcomes.
Detailed Description
Aim-I To develop and test a clinical care pathway that can be utilized in similar epidemic conditions in the future. To study this aim, the investigators will be using the COVID-19 medical surge as a condition to evaluate the framework of delivering care through remote patient monitoring. The success of this care delivery model will be evaluated on ease of model implementation, patient satisfaction, clinical outcomes, and the utilization of shared decision making. Aim-II To evaluate remote patient monitoring for appropriate resource utilization in epidemic and pandemic conditions. To evaluate this aim, the investigators plan to compare the emergency department (ED) visits and in-patient admission of patients with and without wearable remote patient monitoring devices. Additionally, the investigators will compare the number of patients that required critical interventions (mechanical ventilation and ECMO) during the hospital stay. Aim III To evaluate the utilization of wearable technology for upfront predictions of patients that would require in-patient admissions. To evaluate this aim, patients who are diagnosed with COVID-19 and are undergoing self-quarantine will be closely monitored using a wearable device, and shared-clinical decisions will be made based on the monitored data and patient diary. The comparison group will be patients undergoing routine standard of care at the hospital. ED visits, in-patient hospital admissions, and patient satisfaction will be the outcome measures compared between the two groups. Aim IV To evaluate the association between early identification of critical, abnormal vital signs and the prevention of serious adverse events. To evaluate this aim, patients in the monitored group and non-monitored group will be compared for ED visits, in-patient admissions, length of hospital stay, and serious adverse events.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Covid-19 positive patient
- •Does not require in-patient admission
Exclusion Criteria
- •Allergic to sensor patch
- •Has implanted pacemaker
- •Has excessive sweating
Outcomes
Primary Outcomes
Number of Monitored Versus Non-Monitored In-patient Admission
Time Frame: 14 days
compare the number of in-patient admissions between the monitored and non-monitored patients
How Many Subjects Needed to Visit the Emergency Department
Time Frame: 14 days
compare the number of participants who visited Emergency Department between both arms
Length of Stay
Time Frame: 14 days
Length of stay of subject if hospitalized
How Many Completed the Patient Satisfaction Survey
Time Frame: 14 days
Survey given to patients who were monitored to ask about satisfaction with the program. A research associate calls enrolled subjects to determine their opinions having participated in the program.
How Many Subjects End up Requiring Mechanical Ventilation and ECMO
Time Frame: 14 days
How often does a subject end up getting mechanical ventilation or ECMO
Serious Adverse Events
Time Frame: 14 days
events requiring extended hospital stay